Heart rate manipulation in Dilated Cardiomyopathy: Assessing the role of Ivabradine
Conclusion Addition of Ivabradine to standard therapy in patients with DCM and symptomatic HF and targeting a heart rate <70/min improves symptoms, quality of life and various echocardiographic parameters.
Source: Indian Heart Journal - Category: Cardiology Source Type: research
More News: Beta-Blockers | Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | Heart | Heart Failure | India Health